Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage

Jean-Marc Rolain (1) , Patrice Francois (2) , David Hernandez (3) , Fadi Bittar (1) , Herve Richet (4) , Ghislain Fournous (1) , Yves Mattenberger , Emmanuelle Bosdure , Nathalie Stremler (5) , Jean-Christophe Dubus , Jacques Sarles (5) , Martine Reynaud-Gaubert (1) , Stephanie Boniface , Jacques Schrenzel (6) , Didier Raoult (4, 1)

1 URMITE - Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes
2 Central Lab of Bacteriology and Genomic Research Lab
3 Dept Tecnico Conafe
4 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
5 TIMONE - Hôpital de la Timone [CHU - APHM]
6 HUG - Hôpitaux Universitaires de Genève

Background Staphylococcus aureus is a major human pathogen responsible for a variety of nosocomial and community-acquired infections. Recent reports show that the prevalence of Methicillin-Resistant S. aureus (MRSA) infections in cystic fibrosis (CF) patients is increasing. In 2006 in Marseille, France, we have detected an atypical MRSA strain with a specific antibiotic susceptibility profile and a unique growth phenotype. Because of the clinical importance of the spread of such strain among CF patients we decided to sequence the genome of one representative isolate (strain CF-Marseille) to compare this to the published genome sequences. We also conducted a retrospective epidemiological analysis on all S. aureus isolated from 2002 to 2007 in CF patients from our institution. Results CF-Marseille is multidrug resistant, has a hetero-Glycopeptide-Intermediate resistance S. aureus phenotype, grows on Cepacia agar with intense orange pigmentation and has a thickened cell wall. Phylogenetic analyses using Complete Genome Hybridization and Multi Locus VNTR Assay showed that CF-Marseille was closely related to strain Mu50, representing vancomycin-resistant S. aureus. Analysis of CF-Marseille shows a similar core genome to that of previously sequenced MRSA strains but with a different genomic organization due to the presence of specific mobile genetic elements i.e. a new SCCmec type IV mosaic cassette that has integrated the pUB110 plasmid, and a new phage closely related to phiETA3. Moreover this phage could be seen by electron microscopy when mobilized with several antibiotics commonly used in CF patients including, tobramycin, ciprofloxacin, cotrimoxazole, or imipenem. Phylogenetic analysis of phenotypically similar h-GISA in our study also suggests that CF patients are colonized by polyclonal populations of MRSA that represents an incredible reservoir for lateral gene transfer. Conclusion In conclusion, we demonstrated the emergence and spreading of a new isolate of MRSA in CF patients in Marseille, France, that has probably been selected in the airways by antibiotic pressure. Antibiotic-mediated phage induction may result in high-frequency transfer and the unintended consequence of promoting the spread of virulence and/or antibiotic resistance determinants. The emergence of well-adapted MRSA is worrying in such population chronically colonized and receiving many antibiotics and represents a model for emergence of uncontrollable super bugs in a specific niche.

Mots clés: Cystic Fibrosis; Cystic Fibrosis Patient; Colistin; Lateral Gene Transfer; Multi Locus Sequence Typing

Domaines: Bactériologie

Jean-Marc Rolain, Patrice Francois, David Hernandez, Fadi Bittar, Herve Richet, et al.. Genomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage. Biology Direct, 2009, 4 (1), ⟨10.1186/1745-6150-4-1⟩. ⟨hal-01478692⟩